CYTK

Cytokinetics Stock Price

18.73
-1.12 (-5.64%)
Upgrade to Real-Time
Afterhours (Closed)
18.73
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Cytokinetics Inc CYTK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.12 -5.64% 18.73 00:00:05
Open Price Low Price High Price Close Price Prev Close
19.51 18.34 20.355 18.73 19.85
Bid Price Ask Price Spread News
18.50 23.50 5.00 2 2
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
16,492 4,026,819 $ 19.17 $ 77,210,594 1,096,030 8.00 - 30.14
Last Trade Time Type Quantity Stock Price Currency
16:52:01 priorref 1,606 $ 18.73 USD

Cytokinetics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.33B 70.78M 59.83M $ 26.87M $ - -2.11 -10.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cytokinetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYTK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week21.1822.47518.3420.67712,939-2.45-11.57%
1 Month20.0024.2718.3421.50703,282-1.27-6.35%
3 Months17.4324.2716.0520.57902,2291.307.46%
6 Months24.2530.1414.7119.371,257,867-5.52-22.76%
1 Year14.8830.148.0019.261,065,8863.8525.87%
3 Years7.9530.145.7514.76683,80310.78135.6%
5 Years6.6530.145.7513.72589,91312.08181.65%

Cytokinetics Description

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatment for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.


Your Recent History
NASDAQ
CYTK
Cytokineti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.